EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Drug resistance in Mycobacterium tuberculosis: An evolutionary perspective and its adaptation to the lung microenvironment

Satyendra Shukla, Nitin Bhardwaj, Ashutosh Singh

The Microbe · 2024-12 · 5 · 100189

DOI: 10.1016/j.microb.2024.100189 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Microbe, 2024-12. Verfasst von Satyendra Shukla und 2 weiteren Autor:innen. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: India Ministry of Science & Technology Department of Biotechnology, Department of Science and Technology, Ministry of Science and Technology, India, Indian Council of Medical Research.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A highly specialized airborne human intracellular pathogen, Mycobacterium tuberculosis ( Mtb ), causes the disease tuberculosis (TB), with one death per second and approximately 10 million cases per year worldwide. Mtb has emerged as a health risk due to its ability to adapt to drugs . The emergence of drug-resistant Mtb is affected by factors such as drug-resistant gene mutations, the efficacy of TB treatment, genetic background of the strain, and its ability to adapt to host and specific environmental conditions. Mutations in gene coding for drug targets are the evident reason for drug resistance and are believed to arise mainly through single-step chromosomal mutations, single nucleotide polymorphisms (SNPs), and insertion-deletions. Stepwise fixation of mutations leads to acquired drug resistance, resulting in the gradual development of multiple types of drug-resistant Mtb strains. Approximately 25 % of the world population demonstrates some level of immunological response against Mtb infection that may remain dormant (TB infection) or develop into active disease (TB disease). The interaction of Mtb with the host during the early stages of infection can influence the disease outcome, driving the development of active, latent, or resistant TB. The adaptation of bacterial strains in the lung environment during the course of infection depends on their dynamic and unique cell envelope, their composition and metabolic responses in drug-resistant strains. Drug-susceptible and drug-resistant bacteria will adapt to the lung environment in distinct ways. In this review, we have explored the evolution of drug-resistant strains and their adaptation to the changing lung environment.

Förderung

  • India Ministry of Science & Technology Department of Biotechnology
  • Department of Science and Technology, Ministry of Science and Technology, India
  • Indian Council of Medical Research
  • University Grants Commission
  • University of Lucknow
  • Bristol-Myers Squibb

Zitieren

APA

Shukla, S., Bhardwaj, N., & Singh, A. (2024). Drug resistance in Mycobacterium tuberculosis: An evolutionary perspective and its adaptation to the lung microenvironment. The Microbe, 5, 100189. https://doi.org/10.1016/j.microb.2024.100189

Vancouver

Shukla S, Bhardwaj N, Singh A. Drug resistance in Mycobacterium tuberculosis: An evolutionary perspective and its adaptation to the lung microenvironment. The Microbe. 2024;5:100189. doi:10.1016/j.microb.2024.100189

BibTeX
@article{Shukla2024,
  author = {Shukla, Satyendra and Bhardwaj, Nitin and Singh, Ashutosh},
  title = {Drug resistance in Mycobacterium tuberculosis: An evolutionary perspective and its adaptation to the lung microenvironment},
  journal = {The Microbe},
  year = {2024},
  volume = {5},
  pages = {100189},
  doi = {10.1016/j.microb.2024.100189}
}
Kostenlos starten →